How impaired liver lactate metabolism drives age-related muscle loss

Researchers have pinpointed lactate accumulation in skeletal muscle as the root molecular cause of sarcopenia, the severe age-related decline in muscle mass and strength. The mechanism is systemic: aging reduces the liver's capacity to clear lactate, leading to intracellular acidification that impairs muscle contractile function. In mouse models, pharmacological activation of HIF1α—a master regulator of hypoxic responses—both systemically and specifically in the liver reversed both the age-associated decline in lactate tolerance and sarcopenia itself. The underlying mechanism involved depletion of NAD+ (nicotinamide adenine dinucleotide), an essential cofactor for muscle metabolism. This finding dismantles the tissue-siloed view of aging and underscores sarcopenia as a failure of inter-organ communication: the liver and muscle can no longer maintain their metabolic dialogue. For longevity-focused readers, this suggests that optimizing hepatic function and NAD+ status—via sirtuin activators, precursors like NMN, or high-intensity exercise—may deserve priority over protein-centric muscle-building protocols.